Sign inJoin waitlistJoin the waitlist

Stephen Boorjian

Chair, Department of Urology · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Department of Urology · Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Urologic Oncology Mayo Clinic College of Medicine and Science
2012–2013
Weill Cornell Medical College
2007–2012
New York Presbyterian Hospital
2000–2007
Harvard Medical School
1996–2000

Research

Epidemiology of Renal Cell Carcinoma
Review · European Urology · 2019 · 1,208 citations
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Systematic review or meta-analysis · The Journal of Urology · 2016 · 1,110 citations
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy
The Journal of Urology · 2008 · 541 citations

RT
Robert Thompson
228 papers · 4 as a resident
Bradley Leibovich
171 papers · 12 as a fellow
John Cheville
152 papers
Igor Frank
136 papers · 3 as a fellow
Jeffrey Karnes
127 papers
Matthew Tollefson
118 papers · 5 as a resident
Vidit Sharma
96 papers · 30 as a resident
Brian Costello
56 papers
SS
Shahrokhf Shariat
45 papers
Paras Shah
44 papers · 17 as a resident
Abhinav Khanna
39 papers · 18 as a fellow
Sounak Gupta
38 papers · 4 as a resident

Grants

Prospective Validation of a Multi-Marker Prostate Cancer Prediction Model
National Cancer Institute · R01
PI · $1.9M · Sloan-Kettering Inst Can Research
2012–2017

Clinical trials

Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
Principal investigator · Terminated · Phase 2
Mayo Clinic
2020–2023
Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer
Principal investigator · Completed
Mayo Clinic
2019–2024
ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
Principal investigator · Completed · Phase 3
Ferring Pharmaceuticals
2016–2023